Septerna (SEPN) Non-Current Assets (2023 - 2026)

Septerna (SEPN) recorded quarterly Non-Current Assets of $201.6 million in Q1 2026, up 8.86% quarter-over-quarter from $185.2 million in Q4 2025, and up 120.24% on a YoY basis from $91.6 million in Q1 2025.

Septerna (SEPN) Non-Current Assets (2023 - 2026) Analysis & Trends

Septerna's Non-Current Assets history runs 4 years deep, the most recent figure standing at $201.6 million for Q1 2026.

  • In Q1 2026, Non-Current Assets rose 120.24% year-over-year to $201.6 million; the TTM figure through Mar 2026 stood at $582.9 million (up 132.85% YoY), while the FY2025 annual figure was $185.2 million, up 85.72% from the prior year.
  • Non-Current Assets was $201.6 million for Q1 2026 at Septerna, up from $185.2 million in the prior quarter.
  • In the past five years, Non-Current Assets ranged from a high of $201.6 million in Q1 2026 to a low of $18.2 million in Q4 2023.
  • Historically, Non-Current Assets has averaged $104.2 million across 4 years, with a median of $95.6 million in 2024.
  • The sharpest annual moves came in 2024 and 2025: Non-Current Assets surged 448.3% in 2024, then soared 85.72% in 2025.
  • A 4-year view of Non-Current Assets shows it stood at $18.2 million in 2023, then soared by 448.3% to $99.7 million in 2024, then jumped by 85.72% to $185.2 million in 2025, then advanced by 8.86% to $201.6 million in 2026.
  • The last three Non-Current Assets figures came in at $201.6 million (Q1 2026), $185.2 million (Q4 2025), and $115.0 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Assets (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - 62,953.78
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - 289.41 Mn
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - 4.56 Mn
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 486.60 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - 30.30 Mn
7 Psyence Biomedical 212.16 Bn 212.16 Bn - 5.18 Mn
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 14.75 Bn
9 Abivax 91.96 Bn 91.96 Bn - 39.71 Mn
10 Septerna 1.62 Bn 1.62 Bn - 201.63 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 201.63 Mn
Dec 31, 2025 185.22 Mn
Sep 30, 2025 114.97 Mn
Jun 30, 2025 81.09 Mn
Mar 31, 2025 91.55 Mn
Dec 31, 2024 99.73 Mn
Sep 30, 2024 40.87 Mn
Dec 31, 2023 18.19 Mn